Type 2 Diabetes, PNPLA3 rs738409 Polymorphism, and the Risk of Liver Cirrhosis: Analysis of Taiwan Biobank.

chronic disease BUN (mg/dl) 0.996 0.954–1.040 liver observational study polymorphism type 2 diabetes

Journal

Frontiers in genetics
ISSN: 1664-8021
Titre abrégé: Front Genet
Pays: Switzerland
ID NLM: 101560621

Informations de publication

Date de publication:
2022
Historique:
received: 30 11 2021
accepted: 22 02 2022
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 26 3 2022
Statut: epublish

Résumé

Type 2 diabetes (T2D) and liver cirrhosis remain significant public health threats in Taiwan. These conditions are reported to be associated with the rs738409 polymorphism of the

Identifiants

pubmed: 35330730
doi: 10.3389/fgene.2022.822700
pii: 822700
pmc: PMC8940239
doi:

Types de publication

Journal Article

Langues

eng

Pagination

822700

Informations de copyright

Copyright © 2022 Hsueh, Nfor, Hsu, Yang and Liaw.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Liver Int. 2017 Feb;37(2):251-258
pubmed: 27566448
J Gastroenterol Hepatol. 2015 May;30(5):821-9
pubmed: 25641744
Diabetologia. 2019 Apr;62(4):644-654
pubmed: 30673802
J Hepatol. 2019 Jan;70(1):151-171
pubmed: 30266282
Diabetes Care. 2007 Mar;30(3):734-43
pubmed: 17327353
Int J Mol Sci. 2019 Mar 14;20(6):
pubmed: 30875804
Int J Environ Res Public Health. 2020 Apr 20;17(8):
pubmed: 32325957
Ann Hepatol. 2011 Jan-Mar;10(1):56-62
pubmed: 21301011
Semin Diagn Pathol. 2019 Nov;36(6):389-394
pubmed: 31395291
BMC Med. 2014 Sep 18;12:145
pubmed: 25242656
Int J Obes (Lond). 2010 Jan;34(1):190-4
pubmed: 19844213
Hepatology. 2010 Sep;52(3):904-12
pubmed: 20648472
Diabetes Metab Res Rev. 2019 Sep;35(6):e3157
pubmed: 30901133
Hepatology. 2020 Jul;72(1):88-102
pubmed: 31630428
J Gastroenterol. 2016 Apr;51(4):370-9
pubmed: 26337813
Lancet Gastroenterol Hepatol. 2020 Mar;5(3):245-266
pubmed: 31981519
Sci Rep. 2018 Sep 5;8(1):13235
pubmed: 30185902
Liver Int. 2020 Feb;40(2):405-415
pubmed: 31815349
J Gastroenterol Hepatol. 2002 Jun;17(6):677-81
pubmed: 12100613
Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:24-7
pubmed: 16225467
Clin Gastroenterol Hepatol. 2020 Apr;18(4):935-944.e3
pubmed: 31419571
Liver Int. 2007 Apr;27(3):335-9
pubmed: 17355454
Am Fam Physician. 2019 Dec 15;100(12):759-770
pubmed: 31845776

Auteurs

Kuan-Chun Hsueh (KC)

Department of Surgery, Tungs' Taichung Metro Harbor Hospital, Taichung, Taiwan.
Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.

Oswald Ndi Nfor (ON)

Department of Public Health and Institute of Public Health, Chung Shan Medical University, Taichung, Taiwan.

Shu-Yi Hsu (SY)

Department of Public Health and Institute of Public Health, Chung Shan Medical University, Taichung, Taiwan.

Shun-Fa Yang (SF)

Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Department of Medical Research, Chung Shan Medical University Hospital, Taichung, Taiwan.

Yung-Po Liaw (YP)

Department of Public Health and Institute of Public Health, Chung Shan Medical University, Taichung, Taiwan.
Department of Medical Imaging, Chung Shan Medical University Hospital, Taichung City, Taiwan.

Classifications MeSH